Schedule Update - effective 1 March 2003 (text extract)

This is the text extract for Schedule Update - effective 1 March 2003, browse documents here.

PHARMAC

Pharmaceutical Management Agency

New Zealand Pharmaceutical Schedule

UPDATE

Effective 1 March 2003

Cumulative Update for January, February & March 2003

Contents

Summary of PHARMAC decisions effective 1 March 2003 ............................. 3 Glivec (imatinib mesylate) subsidised as first line treatment for CML ...................................................................... 4 Asthma Self Management and the Responsible Use of Inhaled Corticosteroids .............................................................................................. 4 Paracetamol oral liquids – Paracare ............................................................... 5 Reference pricing of blood glucose test strips ............................................... 5 Calcium Channel Blockers ............................................................................. 6 Possible decisions for implementation 1 April 2003 ...................................... 6 Tender News ................................................................................................. 7 Sole Subsidised Supply products cumulative to March 2003 ........................ 8 New Listings ............................................................................................... 15 Changes to Restrictions ............................................................................... 17 Changes to Subsidy and Manufacturer’s Price ............................................ 19 Changes to Sole Subsidised Supply ............................................................. 24 Changes to PSO .......................................................................................... 24 Delisted Items ............................................................................................. 25 Items to be Delisted .................................................................................... 32 Section H changes ...................................................................................... 37 Index ........................................................................................................... 38

Summary of PHARMAC decisions

EFFECTIVE 1 MARCH 2003

New Listings (page 16) • Ethinyloestradiol with Gestodene tab 20 mg with gestodene 75 mg and 7 inert tab (Melodene) – 1 x 28 tablet pack size (p’code 2112191) to replace 3 x 28 tablet pack • Medroxyprogesterone acetate inj 150 mg per ml, 1 ml (Depo-Provera) – temporary pack listed to replace prefilled syringe (p’code 2113929). Available on a PSO • Pamidronate disodium (Pamisol) inj 3 mg per ml, 10 ml (p’code 2113759) and 6 mg per ml, 10 ml (p’code 2113775) – Special Authority – Hospital pharmacy [HP3] • Fluphenazine decanoate (Modecate) inj 100 mg per ml, 1 ml (p’code 210951) – Retail pharmacy-specialist. Available on a PSO Changes to Sole Subsidised Supply (pages 9–14) • Refer to the bold entries in the cumulative sole subsidised supply table Changes to Restrictions (page 17) • Imatinib mesylate cap 100 mg (Glivec) Increased subsidy (pages 19–20) • Amlodipine tab 5 mg, 10 mg (Norvasc) • Cabergoline tab 0.5 mg (Dostinex) • Felodipine tab 2.5 mg, 5 mg, 10 mg (Plendil ER) • Nifedipine tab long-acting 10 mg (Adalat), 30 mg and 60 mg (Adalat Oros) Decreased subsidy (pages 19–20) • Gliclazide tab 80 mg (Diamicron) • Glucose oxidase blood diagnostic test with peroxidase (Ascensia Glucodisc, Advantage II, Glucocard, Glucometer Esprit, Accutrend, BM-Test 1-44, Glucometer Elite and Precision Plus) • Amoxycillin clavulanate tabs and granules for oral liquids 125 mg/ 31.5 mg per 5 ml and 250 mg/62.5 mg per 5 ml (Augmentin and Synermox) • Clonazepam tab 500 µg and 2 mg (Paxam and Rivotril) • Fluphenazine decanoate inj 12.5 mg per 0.5 ml, 0.5 ml and 25 mg per ml, 1 ml (Modecate and Baxter) Changes to Section H (page 37) Part 1 – General Rules for Hospital Pharmaceuticals – Amendment to Rule 9, Pharmaceutical Cancer Treatments

All decisions related to news items are effective from 1 March unless otherwise indicated 3

Glivec (imatinib mesylate) subsidised as first line treatment for CML

From 1 March 2003 the Special Authority access criteria for imatinib mesylate (Glivec) will be widened to include first line use in patients in the chronic phase of Chronic Myeloid Leukaemia. Studies show that imatinib mesylate (Glivec) is an effective treatment for CML, and PHARMAC has been able to reach an agreement with the drug’s supplier, Novartis, to enable it to be subsidised for this group of patients. This means that about 50 more people a year will be able to have fully subsidised access to the drug. Full details of the Special Authority criteria are listed on page 17 of this Update. Glivec application forms are available from the Glivec Co-ordinator and on the PHARMAC website: www.pharmac.govt.nz. All applications should be sent to the Glivec Co-ordinator, Ministry of Health, Private Bag 92 522 Auckland. Phone: 09 580 9176, fax: 09 580 9205, email: murray@ppc.govt.nz. Prescriptions for Glivec are to be sent to the Glivec Co-ordinator who will arrange for delivery directly to patients. Any queries should be addressed to the Glivec Co-ordinator at the above address.

Asthma Self Management and the Responsible Use of Inhaled Corticosteroids

Professor Ian Town officially launched the Asthma Self Management and the Responsible Use of Inhaled Corticosteroids (ICS) campaign on 12 February 2003 in Wellington. The campaign is co-ordinated by PHARMAC and supported by a broad cross section of the medical community, including general practitioners, asthma educators, nurses and pharmacists, and reflects the recommendations of the New Zealand Guidelines Group, released last year. The objective of this campaign is to encourage adults to more effectively manage their asthma using the lowest effective dose of inhaled corticosteroids. The campaign also promotes the use of asthma self-management plans. Health professionals have been sent an Asthma Management Resource kit, which contains information on inhaled corticosteroid prescribing and a sample patient information pack. Posters and a further 10 patient asthma information packs will be sent to health professionals by mid March 2003. Additional patient packs can be ordered by using the fax order sheet in the Asthma Management Resource kit. To get additional fax order sheets either fax a request to 0800 222 240 or phone PHARMAC on 0800 66 00 50.

All decisions related to news items are effective from 1 March unless otherwise indicated 4

Radio and press advertising to inform the public of the campaign is planned to start in mid March 2003. The aim of this advertising is to inform patients with asthma that their asthma medication may need reviewing and they should discuss their asthma medication with a relevant health professional. Note: Until 30 April 2003, 20 peak-flow meters (instead of 10) can be ordered on Wholesale Supply Order (WSO) forms.

Paracetamol oral liquids – Paracare

The Pharmaceutical Schedule lists the Paracare brand of paracetamol oral liquids as fully funded. However PSM, the supplier of Paracare oral liquids has increased the price for these products. These price increases have not been reflected in the Pharmaceutical Schedule Updates as there is a current dispute between Pharmac and PSM concerning the price increases.

Reference pricing of blood glucose test strips

Reference pricing of blood glucose test strips takes effect from 1 March 2003. From this date Ascensia Glucodisc will be the only fully subsidised blood glucose test strip. Patients using subsidised test strips other than Ascensia Glucodisc have the following options: 1) continue to use their current meters and test strips and pay the small manufacturer’s surcharge on test strips when they have a prescription dispensed at a pharmacy; or 2) have the prescription filled by Diabetes Supplies Limited (DSL) mail order service and not pay the manufacturer’s surcharge. Patients will need to contact DSL for details of this service; or 3) swap to the fully funded test strips, however patients may need to purchase a new meter. Before a patient considers swapping meters they should discuss it with their doctor or diabetes nurse educator. DSL contact details are as follows: Diabetes Supplies Limited, P.O.Box 54, Oamaru Phone: 0800 DIABETES (0800 342 238) Email: info@diabetes.org.nz Website address: www.diabetes.org.nz/shop/cfm

All decisions related to news items are effective from 1 March unless otherwise indicated 5

Calcium Channel Blockers

PHARMAC has increased the subsidy on felodipine (Plendil ER) tablets 2.5mg, 5mg and 10mg to match AstraZeneca’s notified price increase effective 1 March 2003. As a result the base subsidy on amlodipine (Norvasc) and nifedipine (Adalat 10 and Adalat Oros) has also been increased to match the new reference price effective 1 March 2003. The Felo ER brand of felodipine has been delisted effective 1 March 2003 and the sole subsidised supply agreement between Pacific Pharmaceuticals and PHARMAC has been terminated.

Looking forward

This section is designed to alert both pharmacists and prescribers to possible future changes. It may assist pharmacists to manage stock levels and keep prescribers up-to-date with proposals to change the Pharmaceutical Schedule. Proposals under consideration The following areas of health care funding are currently under consideration. The PHARMAC Board will be reviewing these proposals, and the decisions taken will be published in future Updates. The dates represented below are the earliest date that these proposals may be implemented. Possible decisions for implementation 1 April 2003 • Alpha blockers – reference pricing

All decisions related to news items are effective from 1 March unless otherwise indicated 6

Tender News

Subsidy Changes

Chemical Name Presentation; Pack size and type Current subsidy New Tender subsidy Date of Sole Supply Date of Brands affected by new brand sole reference pricing subsidy (and supplier) supply and delisting

Dipyridamole

Tab long-acting 150 mg; 60 tablets, bottle

$22.39 (with Special Authority)

$11.95 1April (with 2003 Special Authority) $6.62 1 April 2003

Pytazen SR (Douglas)

1 July Persantin PL 2003

Ethinyloestradiol Tab 35 µg with 500 µg $9.45 with noresthisterone Norethisterone and 7 inert tablets; 84 tablets, calendar pack Triazolam Tab 0.25 mg; 100 tablets, bottle $5.20

Norimin (Pharmacia)

1 July 2003

Brevinor 28

$3.45

1 April 2003

Hypam (Pacific)

1 July 2003

Halcion

Sole Subsidised Supply Changes

Chemical Name Presentation; Pack size Sole Supply brand Date of Sole Supply Brands affected by (and supplier) reference pricing and delisting Minidiab (Pharmacia) m-Hydrocortisone (Multichem) 1 April 2003 1 April 2003 Glipid Douglas, Pharmacia, Apo-Hydrocortisone, PSM

Glipizide Hydrocortisone

5 mg tablets; 100 tablets Powder; 25 g

Indomethacin Indomethacin Indomethacin Indomethacin

Cap 25 mg; 100 capsules, bottle Cap 50 mg; 100 capsules, bottle

Rheumacin (Pacific) Rheumacin (Pacific)

1 April 2003 1 April 2003 1 April 2003 1 April 2003 1 April 2003 MDS Quickstick

Cap long-acting 75 mg; 100 capsules, Rheumacin Bottle (Pacific) Suppos 100 mg; 30 suppositories, Arthrexin Blister (Pacific) MDS Quickcard (MDS)

Pregnancy Tests– HCG Urine Cassette; 25 Cassettes

All decisions related to news items are effective from 1 March unless otherwise indicated 7

Sole Subsidised Supply products cumulative to March 2003

Sole Subsidised Supply Products – cumulative to March 2003

Generic Name

Acipimox Acitretin Aciclovir

Presentation

Cap 250 mg Cap 10 mg & 25 mg Tab 200 mg Tab 400 mg & 800 mg Tab dispersible 200 mg, 400 mg & 800 mg Cream Tab 100 mg & 300 mg Oral liquid 1 mg per ml Tab 5 mg with hydrochlorothiazide 50 mg Tab 10 mg Tab 25 mg Tab 50 mg Cap 250 mg & 500 mg Grans for oral liq 125 mg per 5 ml & 250 mg per 5 ml Inj 250 mg Inj 500 mg Inj 1 g Oral drops 125 mg per 1.25 ml Inj 10 mg per ml, 1 ml Tab 50 mg & 100 mg Inj 400 µg 1 ml Inj 600 µg 1 ml Inj 1200 µg 1 ml Eye drops 0.5% Eye drops 1.0% Tab 10 mg Metered aqueous nasal spray, 50 µg per dose & 100 µg per dose Tab 16 mg Oint 0.1%, 30 g & 100 g Crm 0.1%, 30 g & 100 g Eye drops 0.5% Tab 200 mg Suppos 10 mg Tab 2.5 mg Tab 10 mg Metered aqueous nasal spray, 50 µg per dose & 100 µg per dose Tab 5 mg Tab 10 mg Tab 12.5 mg, 25 mg & 50 mg

Brand Name Expiry Date*

Olbetam Neotigason Apo-Aciclovir Alpha-Aciclovir Acicvir AFT Progout Biomed Amizide Amitrip Amitrip Amitrip Ospamox Ospamox Ospamox Ibiamox Ibiamox Ibiamox Ospamox Paediatric Drops Baxter Loten AstraZeneca AstraZeneca AstraZeneca Atropt Atropt Pacifen Alanase Aqueous Vergo Beta Ointment Beta Cream Apo-Betaxolol Fibalip Fleet Alpha-Bromocriptine Alpha-Bromocriptine Butacort Aqueous Pacific Buspirone Pacific Buspirone Captohexal 2004 2004 2003

Aqueous Cream Allopurinol Amiloride Amiloride with hydrochlorothiazide Amitriptyline

2005 2003 2005 2003 2005

Amoxycillin

2003

2005

Apomorphine hydrochloride Atenolol Atropine sulphate

2005 2003 2005

Baclofen Beclomethasone dipropionate Betahistine dihydrochloride Betamethasone valerate Betaxolol hydrochloride Bezafibrate Bisacodyl Bromocriptine mesylate Budesonide Buspirone hydrochloride Captopril

2003 2003 2003 2005 2004 2005 2004 2005 2003 2004 2004

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 8

Sole Subsidised Supply Products – cumulative to March 2003

Generic Name

Cefaclor monohydrate Cefamandole nafate Ceftriaxone sodium Cefuroxime sodium Celiprolol Cephalexin monohydrate

Presentation

Brand Name Expiry Date*

2004 2005 2005 2005 2004 2005

Cephazolin sodium Cetirizine hydrochloride Charcoal Clomipramine hydrochloride Chloramphenicol Chlorothiazide Clindamycin hydrochloride Clindamycin phosphate Clobetasol propionate

Clomipramine hydrochloride Clonidine Clonidine hydrochloride Clotrimazole

Colestipol hydrochloride Co-Trimoxazole

Cyclizine lactate Cyclophosphamide Cyproterone acetate Cyproterone acetate with ethinyloestradiol

Cap 250 mg Clorotir Grans for oral liq 125 mg per 5 ml Clorotir Inj 1 g Mandol Inj 500 mg Novartis Inj 1 g Novartis Inj 750 mg Zinacef Tab 200 mg Celol Tab 500 mg Keflex Cap 250 mg Keflex Grans for oral liquid 125 mg per 5 ml Keflex Grans for oral liquid 250 mg per 5 ml Keflex Inj 500 mg Novartis Inj 1 g Novartis Tab 10 mg Razene 50 g per 300 ml oral liquids Carbosorb Tab 10 mg Clopress Eye drops 0.5% Chlorsig Eye oint 1% Chlorsig Oral liq 50 mg per ml Biomed Cap 150 mg Dalacin C Inj 150 mg per ml Dalacin C Crm 0.05% Dermol Oint 0.05% Dermol Scalp app 0.05% Dermol Tab 25 mg Clopress Tab 150 µg Catapres Tab 25 µg Dixarit Vaginal crm 1% with applicators Clocreme Vaginal crm 2% with applicators Clotrimaderm 2% Pessaries 100 mg with applicator Clotrihexal Pessary 500 mg with applicator Clotrihexal Crm 1% Clocreme Sachets 5 g Colestid Tab Trimethoprim 80 mg and Trisul sulphamethoxazole 400 mg Oral liq sugar-free trimethoprim 40 mg Trisul and sulphamethoxazole 200 mg per 5 ml Inj 50 mg per ml, 1 ml Valoid Tab 50 mg Cycloblastin Tab 50 mg Siterone Tab 2 mg with ethinyloestradiol Estelle 35 35 µg and 7 inert tabs

2005 2005 2005 2005 2005 2005 2005 2005 2003 2005 2003 2005 2005 2004

2005 2004 2005 2005 2004 2005 2003 2004

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 9

Sole Subsidised Supply Products – cumulative to March 2003

Generic Name

Danazol Danthron with poloxamer

Presentation

Cap 100 mg Cap 200 mg Oral liq 25 mg with poloxamer 200 mg per 5 ml Oral liq 75 mg with poloxamer 1g per 5 ml Inj 500 mg per 10 ml vial Oral liq 1 mg per ml Range of sizes Tab 5 mg & 10 mg Tab 10 mg Tab 2.5 mg with 25 µg atropine sulphate Tab 30 mg & 60 mg Cap long-acting 120 mg Tab 50 mg Tab 120 mg Oral drops 10% Enema conc 18% Suppository 100 mg with bisacodyl 10 mg Tab 50 mg with total sennosides 8 mg Tab 2 mg & 4 mg Tab 100 mg Ointment Inj 500 µg per ml, 1 ml Tab 500 mg Grans for oral liquid 200 mg per 5 ml Grans for oral liquid 400 mg per 5 ml Tab 400 mg Tab 500 µg Tab 200 mg Cap 50 mg & 100 mg Cap 250 mg & 500 mg Inj 250 mg, 500 mg & 1 g Inj 500 mg per 10 ml Inj 500 mg per 20 ml Tab dispersible 20 mg Cap 20 mg Tab 5 mg 50 µg per ml oral liquid Tab 40 mg Tab 500 mg

Brand Name Expiry Date*

D-Zol D-Zol Conthram Conthram Forte Desferal Biomed Ortho All-flex, Ortho Coil Pro-Pam Merbentyl Diastop Dilzem Dilzem SR Coloxyl Coloxyl Coloxyl Oral Drops Coloxyl Coloxyl Laxsol Dosan Doxine AFT Baxter Eromycin E-Mycin E-Mycin E-Mycin Femulen Etidrate Vepesid Staphlex Flucloxin Baxter Baxter Fluox Fluox Apo-Folic Acid Biomed Diurin 40 Diurin 2004 2005 2005 2003 2005 2005 2004 2005 2005 2004

Desferrioxamine mesylate Dexamethasone Diaphragm Diazepam Dicyclomine hydrochloride Diphenoxylate hydrochloride with atropine sulphate Diltiazem hydrochloride Docusate sodium

Docusate sodium with bisacodyl Docusate sodium with sennosides Doxazosin mesylate Doxycycline hydrochloride Emulsifying Ointment BP Ergometrine maleate Erythromycin estolate Erythromycin ethyl succinate

2005 2004 2004 2003 2005 2005 2004 2005

Ethynodiol diacetate Etidronate disodium Etoposide Flucloxacillin sodium Fluorouracil sodium Fluoxetine hydrochloride Folic acid Frusemide

2005 2003 2004 2003 2004 2004 2004 2003 2005 2003

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 10

Sole Subsidised Supply Products – cumulative to March 2003

Generic Name

Hydrocortisone with cinchocaine

Presentation

Oint 5 mg with cinchocaine hydrochloride 5 mg per g Suppos 5 mg with cinchocaine hydrochloride 5 mg per g Crm 1% with miconazole nitrate 2%

Brand Name Expiry Date*

Proctosedyl Proctosedyl Micreme H DP Lotn HC Hydrea Methopt Methopt Forte Poly-Tears Ipra 250 Ipra 500 Atrovent Nasal Aqueous Naplin Ismo 20 Duride Lactulose Dicap Lora-tabs Lorapam Baxter Depo-Provera Provera HD Megace K Thrombin Metomin Baxter Baxter Baxter Baxter Methoblastin Methoblastin Prodopa Rubifen Medrol Medrol Depo-Medrol Depo-Medrol with lidocaine 2004 2003 2004 2003 2005 2004 2005 2003 2003 2003 2004 2004 2003 2005 2004 2005 2004 2005 2003 2004 2004

Hydrocortisone with miconazole Hydrocortisone with wool fat and mineral oil Hydroxyurea Hypromellose

Lotn 1% with wool fat hydrous 3% and mineral oil Cap 500 mg Eye drops 0.5% Eye drops 1% Eye drops 0.3% Ipratropium bromide Nebuliser soln 250 µg per ml, 1 ml Nebuliser soln 500 µg per 2 ml, 2 ml Aqueous nasal spray, 0.03% Indapamide Tab 2.5 mg Isosorbide mononitrate Tab 20 mg Tab long-acting 60 mg Lactulose Oral liq 10 g per 15 ml Loperamide hydrochloride Cap 2 mg Loratadine Tab 10 mg Lorazepam Tab 1 mg & 2.5 mg Magnesium sulphate Inj 49.3% Medroxyprogesterone acetate Inj 150 mg per ml, 1 ml syringe Tab 100 mg Megestrol acetate Tab 160 mg Menadione sodium Tab 10 mg Metformin hydrochoride Tab 500 mg & 850 mg Methotrexate Inj 5 mg per 2 ml vial Inj 20 mg per 2 ml vial Inj 50 mg per 2 ml vial Inj 100 mg per 4 ml vial Tab 10 mg Tab 2.5 mg Methyldopa Tab 125 mg, 250 mg & 500 mg Methylphenidate hydrochloride Tab 10 mg Methylprednisolone Tab 4 mg Tab 100 mg Methylprednisolone acetate Inj 40 mg per ml, 1 ml Methylprednisolone Inj 40 mg per ml, acetate with lignocaine with lignocaine 1 ml

2005 2003 2003 2005 2005 2005

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 11

Sole Subsidised Supply Products – cumulative to March 2003

Generic Name

Gentamicin sulphate Glibenclamide

Presentation

Brand Name Expiry Date*

Pharmacia Gliben Gliben Nitroderm TTS Haldol Haldol Concentrate AstraZeneca Solu-Cortef Solu Medrol Solu Medrol Solu Medrol Solu Medrol AstraZeneca Paramax Daktarin Micreme Hypnovel Hypnovel Cytotec RA Morph RA Morph RA Morph RA Morph Baxter Baxter Apo-Nadolol Naphcon Forte Naprosyn SR Naprosyn SR Synflex Synflex Apo-Nicotinic Acid Nyefax Retard Noriday Primolut N Norpress Norpress Mycostatin Baxter Dipentum Dipentum 2005 2005 2004 2005 2005 2003 2005

Inj 40 mg per ml, 2 ml Tab 2.5 mg Tab 5 mg Glyceryl trinitrate TDDS 5 mg & TDDS 10 mg Haloperidol decanoate Inj 50 mg per ml, 1 ml Inj 100 mg per ml, 1 ml Heparinised saline Inj 10 iu per ml, 5 ml Hydrocortisone Inj 50 mg per ml, 2 ml Methylprednisolone sodium Inj 40 mg per ml, 1 ml succinate Inj 62.5 mg per ml, 2 ml Inj 500 mg Inj 1 g Metoclopramide hydrochloride Inj 5 mg per ml, 2 ml Metoclopramide hydrochloride Tab 5 mg with 500 mg paracetamol with paracetamol Miconazole Oral gel 20 mg per g Miconazole nitrate Crm 2% Midazolam Inj 1 mg per ml, 5 ml Inj 5 mg per ml, 3 ml Misoprostol Tab 200 µg Morphine hydrochloride Oral liq 1 mg per ml Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Morphine tartrate Inj 80 mg per ml, 1.5 ml Inj 80 mg per ml 5 ml Nadolol Tab 40 mg & 80 mg Naphazoline hydrochloride Eye drops 0.1% Naproxen Tab long-acting 750 mg Tab long-acting 1,000 mg Naproxen sodium Tab 275 mg Tab 550 mg Nicotinic acid Tab 25 mg, 50 mg, 100 mg & 500 mg Nifedipine Tab long-acting 20 mg Norethisterone Tab 350 µg Tab 5 mg Nortriptyline hydrochloride Tab 10 mg Nortriptyline Tab 25 mg Nystatin Oral liq 100,000 u per ml Oily phenol Inj 5%, 5 ml Olsalazine Cap 250 mg Tab 500 mg

2005 2005 2004 2005 2005 2005 2005

2005 2004 2005 2005 2005 2004 2003 2005 2005 2005 2005 2005 2005

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 12

Sole Subsidised Supply Products – cumulative to March 2003

Generic Name

Ornidazole Pamidronate disodium Paracetamol

Presentation

Tab 500 mg Inj 30 mg per 10 ml Tab 500 mg Suppos 125 mg Suppos 250 mg Tab 0.25 mg Tab 1 mg Grans for oral liquid benzathine 125 mg per 5 ml Grans for oral liquid benzathine 250 mg per 5 ml Eye drops 0.5% Eye drops 1% Eye drops 2% Eye drops 3% Eye drops 4% Eye drops 6% Tab 5 mg Tab dispersible 10 mg & 20 mg Inj 75 mg per ml, 10 ml Inj 150 mg per ml, 10 ml Tab 1 mg, 2 mg & 5 mg Tab 1 mg Tab 2.5 mg Tab 5 mg Tab 20 mg Inj 1.5 mega u Tab 5 mg Tab 200 mg Tab 300 mg Nebuliser soln, 1 mg per ml, 2.5 ml Nebuliser soln, 2 mg per ml, 2.5 ml Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg per 2.5 ml vial, 2.5 ml Tab 5 mg 16% enema with 8% sodium phosphate Inj 0.9% 5 ml, 10 ml & 20 ml Tab 25 mg & 100 mg Oral liquid 5 mg per ml Eye drops 10% Tab 500 mg Tab EC 500 mg

Brand Name Expiry Date*

Tiberal Baxter Pacimol Panadol Panadol Permax Permax AFT AFT Pilopt Pilopt Pilopt Pilopt Pilopt Pilopt Pindol Piram-D AstraZeneca AstraZeneca Hyprosin Apo-Prednisone Apo-Prednisone Apo-Prednisone Apo-Prednisone Cilicaine Antinaus Q 200 Q 300 Ventolin Nebules Ventolin Nebules Duolin 2005 2004 2005 2005 2005 2005 2004

Pergolide Phenoxymethylpenicillin (Penicillin V)

Pilocarpine

Pindolol Piroxicam Potassium chloride Prazosin hydrochloride Prednisone

2004 2003 2005 2004 2005

Procaine penicillin Prochlorperazine Quinine sulphate Salbutamol Salbutamol with ipratropium bromide Selegiline hydrochloride Sodium acid phosphate Sodium chloride Spironolactone Sulphacetamide sodium Sulphasalazine

2005 2004 2003 2004 2004

Selgene Fleet Pharmacia Spirotone Biomed Acetopt Salazopyrin Salazopyrin-EN

2003 2005 2004 2003 2005 2005 2005

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 13

Sole Subsidised Supply Products – cumulative to March 2003

Generic Name

Tamoxifen citrate Tar with triethanolamine lauryl sulphate and fluorescein Temazepam Testosterone cypionate Timolol maleate Tranexamic acid Triazolam Triamcinolone acetonide Triamterene with hydrochlorothiazide Trimethoprim Urea Vancomycin hydrochloride Verapamil hydrochloride Verapamil hydrochloride Vitamins Vitamin B complex Water Zinc and castor oil Zopiclone March changes are in bold type

Presentation

Tab 10 mg & 20 mg Soln 2.3% with triethanolamine lauryl sulphate and fluorescein sodium Cap 20 mg Cap 10 mg Inj long-acting 100 mg per ml, 10 ml Eye drops 0.25% & 0.5% Tab 500 mg Tab 0.125 mg Dental Paste USP 0.1% Tab 50 mg with hydrochlorothiazide 25 mg Tab 300 mg Crm 10% Cap 125 mg & 250 mg Inj 50 mg per ml, 10 ml Tab 40 mg & 80 mg Tab long-acting 240 mg Tab long-acting 120 mg Tab (BPC cap strength) Tab, strong, BPC Purified for inj 5 ml, 10 ml & 20 ml Ointment BP Tab 7.5 mg

Brand Name Expiry Date*

Genox Pinetarsol 2003 2005

Euhypnos Euhypnos Depo Testosterone Apo-Timop Cyklokapron Halcion Oracort Triamizide TMP Nutraplus Vancocin Vancocin Verpamil Verpamil SR Verpamil SR Healtheries Multivitamin tablets Apo-B-Complex Pharmacia Sigma Imovane

2005 2005 2005 2004 2004 2005 2005 2003 2005 2005 2004 2003 2005 2004 2003 2004 2005 2005

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 14

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

New Listings

Effective 1 March 2003

77 ETHINYLOESTRADIOL WITH GESTODENE - Available on a PSO

Tab 20 µg with gestodene 75 µg and 7 inert tab ............. 3.15 (Special Authority does not apply) (6.00) 28 Melodene

Note: Melodene 28 tablet pack size replaces Melodene 84 tablet pack size. 79 MEDROXYPROGESTERONE ACETATE - Available on a PSO

Inj 150 mg per ml, 1 ml ................................................... 8.47 each Depo-Provera

Note: Alternative pack subsidised while Depo-Provera pre-filled syringe is unavailable. 83 PAMIDRONATE DISODIUM - Special Authority

Inj 3 mg per ml, 10 ml ................................................... 76.00 1 Pamisol Inj 6 mg per ml, 10 ml ................................................. 152.00 1 Pamisol Special Authority - Hospital pharmacy [HP3] a) Paget’s disease. b) Tumour-induced hypercalcaemia, only patients under hospice care. c) Tumour-induced osteolysis without hypercalcaemia, only patients under hospice care. d) Specialist must make application.

129 FLUPHENAZINE DECANOATE - Retail pharmacy-specialist

Inj 100 mg per ml, 1 ml - Available on a PSO .............. 168.00 5 Modecate

Effective 1 February 2003

125 ONDANSETRON HYDROCHLORIDE - Hospital pharmacy [HP3]-specialist

a) Not to exceed 6 tablets per prescription; and b) Not more than one prescription per month. Tab disp 4 mg ................................................................ 86.00 Tab disp 8 mg .............................................................. 123.80 Zofran Zydis Zofran Zydis

10 10

131 TRIAZOLAM - Month restriction

Tab 250 µg ...................................................................... 5.20 100 Hypam

161 TIMOLOL MALEATE - Retail pharmacy-specialist

L L

Eye drops 0.25% ............................................................. 4.30 Eye drops 0.5% ............................................................... 4.30

5 ml OP Timoptol 5 ml OP Timoptol

Note: Listing effective 1 January 2003 – 31 March 2003.

These entries were previously referred to as Discontinued followed by a Delist date. They are now listed only by the date of delisting

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Effective 1 January 2003

32 GLUCOSE OXIDASE

Blood diagnostic test with peroxidase ............................ 26.95 50 test OP Ascensia Glucodisc

Note: Ascensia Glucodisc replaces Glucometer Esprit. 89 NAFARELIN ACETATE - Special Authority

Nasal soln 2 mg per ml ................................................ 221.60 (311.63) 8 ml OP Synarel

Note: Synarel 8 ml OP replaces Synarel 10 ml OP . 95 AMOXYCILLIN CLAVULANATE - Available on a PSO

Tab amoxycillin 500 mg with potassium clavulanate 125 mg ..................................... 7.48 Grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml ..................................... 3.43 Grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml .......................................... 5.89 20 100 ml 100 ml Augmentin Augmentin Augmentin

Note: Listing effective 12 December 2002 122 CLONAZEPAM

L L

Tab 500 µg ...................................................................... 9.85 Tab 2 mg ....................................................................... 18.58

100 100

Paxam Paxam Modecate Modecate

129 FLUPHENAZINE DECANOATE - Retail pharmacy-specialist

Inj 12.5 mg per 0.5 ml, 0.5 ml - Available on a PSO ...... 29.00 Inj 25 mg per ml, 1 ml - Available on a PSO .................. 48.75 5 5

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

‡ safety cap reimbursed Sole Subsidised Supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Restrictions

Effective 1 March 2003

134 IMATINIB MESYLATE - Special Authority - access by application

Cap 100 mg .............................................................. 4,800.00 120 Glivec Special Authority criteria and guidelines for Glivec: Application forms are available from, and prescriptions should be sent to: The Glivec Coordinator Tel: 09 580 9176 Fax: 09 580 9205 Email: murray@ppc.govt.nz Level 3, Unisys House, 650 Great South Road, Penrose, Private Bag 92 522, AUCKLAND Special Authority criteria for CML - access by application a) Funded for patients with diagnosis (confirmed by a haematologist) of a chronic myeloid leukaemia (CML) in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy. b) Maximum dose of 600 mg/day for accelerated or blast phase, and 400 mg/day for chronic phase CML c) Subsidised for use as monotherapy only. d) Initial approvals valid seven months. e) Subsequent approval(s) are granted on application and are valid for six months. The first reapplication (after seven months) should provide details of the haematological response. The third re-application should provide details of the cytogenetic response after 14–18 months from initiating therapy. All other re-applications should provide details of haematological response, and cytogenetic response if such data is available. Applications to be made and subsequent prescriptions can be written by a haematologist or an oncologist.

Guideline on discontinuation of treatment for patients with CML

a) Prescribers should consider discontinuation of treatment if after 6 months from initiating therapy a patient did not obtain a haematological response as defined as any one of the following three levels of response: - complete haematologic response (as characterised by an absolute neutrophil count (ANC) > 1.5 x 109/L, platelets > 100 x 109/L, absence of peripheral blood (PB) blasts, bone marrow (BM) blasts < 5% (or FISH Ph+ 0–35% metaphases), and absence of extramedullary disease); or - no evidence of leukaemia (as characterised by an absolute neutrophil count (ANC) > 1.0 x 10 9/L, platelets > 20 x 109/L, absence of peripheral blood (PB) blasts, bone marrow (BM) blasts < 5% (or FISH Ph+ 0-35% metaphases), and absence of extramedullary disease); or - return to chronic phase (as characterised by BM and PB blasts < 15%, BM and PB blasts and promyelocytes < 30%, PB basophils < 20% and absence of extramedullary disease other than spleen and liver). b) Prescribers should consider discontinuation of treatment if after 18 months from initiating therapy a patient did not obtain a major cytogenetic response defined as 0–35% Ph+ metaphases. Special Authority criteria for GIST - access by application a) Funded for patients: - with a diagnosis (confirmed by an oncologist) of unresectable and/or metastatic malignant gastrointestinal stromal tumour (GIST); and - who have immunohistochemical documentation of c-kit (CD117) expression by the tumour. b) Maximum dose of 400 mg/day. c) Applications to be made and subsequent prescriptions can be written by an oncologist. d) Initial and subsequent applications are valid for one year. The re-application criterion is an adequate clinical response to the treatment with imatinib (prescriber determined).

L Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Restrictions – effective 1 January 2003

39 ERYTHROPOIETIN BETA- Special Authority

Inj 1,000 u, pre-filled syringe ......................................... 76.02 6 Recormon Inj 2,000 u pre-filled syringe ........................................ 152.04 6 Recormon Inj 3,000 u pre-filled syringe ........................................ 228.06 6 Recormon Inj 4,000 u pre-filled syringe ........................................ 304.08 6 Recormon Inj 5,000 u pre-filled syringe ........................................ 380.10 6 Recormon Inj 6,000 u pre-filled syringe ........................................ 456.12 6 Recormon Inj 10,000 u pre-filled syringe ...................................... 760.20 6 Recormon Special Authority - Hospital pharmacy [HP3] a) Erythropoietin beta is indicated in the treatment of anaemia associated with chronic renal failure (CRF) where no cause for anaemia other than CRF is detected and there is adequate monitoring of iron stores and iron replacement therapy. b) Erythropoietin beta is to be given only to patients in chronic renal failure with haemoglobin ≤ 100 g/l; and i) glomerular filtration rate ≤ 30 ml/min in non diabetic patients; or ii) glomerular filtration rate ≤ 45 ml/min in diabetic patients iii) haemodialysis or peritoneal dialysis patients. c) Specialist must make application – renal physicians Note. The Cockroft-Gault Formula may be used to estimate glomerular filtration rate (GFR) in persons 18 years and over: (140 – age) x Ideal Body Weight (kg) (ml/min) GFR (male) = 814 x serum creatinine (mmol/l) GFR (female) = Estimated GFR (male) x 0.85

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

‡ safety cap reimbursed Sole Subsidised Supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Subsidy and Manufacturer’s Price

Effective 1 March 2003

31 GLICLAZIDE (↓subsidy)

Tab 80 mg ..................................................................... 39.08 (78.80) 500 Diamicron

32 GLUCOSE OXIDASE (↓subsidy)

Blood diagnostic test with peroxidase ............................ 26.95 50 test OP Ascensia Glucodisc (27.85) Advantage II Glucocard Glucometer Esprit (29.90) Accutrend BM-Test 1-44 (36.11) Glucometer Elite Blood diagnostic test with peroxidase ............................ 53.90 100 test OP (55.70) Precision Plus

58 AMLODIPINE - Special Authority available (↑subsidy)

Tab 5 mg ....................................................................... 12.81 (22.82) Tab 10 mg ..................................................................... 24.38 (34.85) 30 Norvasc 30 Norvasc

58 FELODIPINE (↑subsidy)

Tab long-acting 2.5 mg .................................................... 8.58 Tab long-acting 5 mg ..................................................... 12.81 Tab long-acting 10 mg ................................................... 24.38 30 30 30 Plendil ER Plendil ER Plendil ER

58 NIFEDIPINE - Special Authority available (↑subsidy)

Tab long-acting 10 mg ................................................... 17.16 (17.72) Tab long-acting 30 mg ................................................... 12.81 (19.90) Tab long-acting 60 mg ................................................... 24.38 (29.50) 60 Adalat 10 30 Adalat Oros 30 Adalat Oros

61 GLYCERYL TRINITRATE (↓price)

Oral pump spray 400 µg per dose ................................... 6.99 200 dose OP Nitrolingual Pumpspray

90 CABERGOLINE (↑subsidy)

a) Restriction of two tablets per prescription. b) Special Authority available to waive the above quantity restriction. Tab 0.5 mg .................................................................. 105.03

L Three

Dostinex

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Subsidy and Manufacturer’s Price – effective 1 March 2003 (continued)

95 AMOXYCILLIN CLAVULANATE - Available on a PSO (↓subsidy)

Tab amoxycillin 500 mg with potassium clavulanate 125 mg 6.40 (7.48) Grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml ..................................... 2.75 (3.43) Grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml ....................................... 4.75 (5.89) 20 Augmentin Synermox Augmentin Synermox Augmentin Synermox Paxam Rivotril Paxam Rivotril

100 ml

122 CLONAZEPAM (↓subsidy)

L L

Tab 500 µg ...................................................................... 6.00 Tab 2 mg ....................................................................... 11.00

100 100

129 FLUPHENAZINE DECANOATE - Retail pharmacy-specialist (↓subsidy)

Inj 12.5 mg per 0.5 ml, 0.5 ml - Available on a PSO ...... 17.60 (29.00) Inj 25 mg per ml, 1 ml - Available on a PSO .................. 27.90 (48.75) 5 5 Modecate Baxter Modecate Baxter

Effective 1 February 2003

31 GLICLAZIDE (↓subsidy)

Tab 80 mg ..................................................................... 39.08 78.80 500 Apo-Gliclazide Diamicron

Note: Subsidy reduction applying to Diamicron deferred until 1 March 2003. 34 GLYCEROL - Only on a prescription (↓price)

Suppos 3.6 g ................................................................... 5.15 20 PSM

36 HYDROGEN PEROXIDE (↑price)

Soln 10 vol ...................................................................... 0.75 (1.40) 100 ml PSM

37 PYRIDOXINE HYDROCHLORIDE (↑price)

a) Only on a prescription not exceeding a strength of 100 mg per dose. Tab 100 mg ..................................................................... 5.38 100 (11.35)

Apo-Pyridoxine

40 FERROUS GLUCONATE (↑subsidy)

‡ Oral liq 300 mg per 5 ml .................................................. 5.90 100 ml Fergon

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

‡ safety cap reimbursed Sole Subsidised Supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Subsidy and Manufacturer’s Price – effective 1 February 2003 (continued)

64 MICONAZOLE NITRATE - Not in combination (↑price)

Lotn 2% ........................................................................... 4.36 30 ml OP (10.32) Tincture 2% ..................................................................... 4.36 30 ml OP (12.46) Daktarin Daktarin

65 MENTHOL (↓price)

Crystals ......................................................................... 32.20 (32.80) 100 g PSM

68 TRIAMCINOLONE ACETONIDE WITH GRAMICIDIN, NEOMYCIN AND NYSTATIN Only on a prescription (↓subsidy)

Crm 1 mg with nystatin 100,000 u, neomycin sulphate 2.5 mg and gramicidin 250 µg per g .............................. 3.49 15 g OP Viaderm KC (6.09) Kenacomb Oint 1 mg with nystatin 100,000 u, neomycin sulphate 2.5 mg and gramicidin 250 µg per g .............................. 3.49 15 g OP Viaderm KC (6.09) Kenacomb

73 FLUOCINOLONE ACETONIDE (↑price)

Gel 0.02% ........................................................................ 5.23 30 g OP (7.95) Synalar Gel

83 PAMIDRONATE DISODIUM - Special Authority (↓subsidy)

Inj 3 mg per ml, 10 ml ................................................... 76.00 Inj 6 mg per ml, 10 ml ................................................. 152.00 1 1 Baxter Baxter

91 CEFTRIAXONE SODIUM - Hospital pharmacy [HP3]-specialist (↓subsidy)

a) Subsidised only if prescribed for a dialysis or cystic fibrosis patient; and b) The prescription is endorsed accordingly. Inj 250 mg ....................................................................... 4.00 1 Rocephin IV

96 CIPROFLOXACIN - Retail pharmacy-specialist (↓subsidy)

Tab 250 mg ................................................................... 11.42 (48.16) Tab 500 mg ................................................................... 20.44 (86.68) Tab 750 mg ................................................................... 29.87 (138.16) 28 28 28 Cipflox Ciproxin Cipflox Ciproxin Cipflox Ciproxin

L Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Subsidy and Manufacturer’s Price – effective 1 February 2003 (continued)

110 IBUPROFEN - Special Authority available (↓subsidy)

Tab 200 mg ..................................................................... 2.07 (2.90) Tab 400 mg ..................................................................... 3.55 (15.20) Tab 600 mg ..................................................................... 5.32 (22.80) 100 100 Brufen 100 Brufen Naprosyn IMM Naxen IMM Naprosyn Enteric Naprosyn IMM NaxenIMM Naprosyn EntericIMM I-Profen Panafen

110 NAPROXEN - Special Authority available (↓subsidy)

Tab 250 mg ................................................................... 26.50 Tab EC 250 mg ................................................................ 6.36 Tab 500 mg ................................................................... 53.00 Tab EC 500 mg ................................................................ 6.36 500 120 500 60

116 DEXTROPROPOXYPHENE WITH PARACETAMOL (↑price)

Tab napsylate 50 mg with paracetamol 325 mg ............. 14.50 (22.50) 500 Paradex

119 TRIMIPRAMINE MALEATE (↓subsidy)

Tab 25 mg ....................................................................... 3.19 (6.58) Cap 25 mg ....................................................................... 6.38 Cap 50 mg ..................................................................... 12.00 (23.00) 50 100 100 Surmontil Tripress Tripress Surmontil

125 ONDANSETRON - Hospital pharmacy [HP3]-specialist (↓subsidy)

a) Not to exceed 6 tablets per prescription; and b) Not more than one prescription per month. Tab 4 mg ....................................................................... 86.00 Tab 8 mg ..................................................................... 247.60 Zofran Zofran

10 20

146 FLUTICASONE (↓subsidy)

Aerosol inhaler, 25 µg per dose ....................................... 5.12 120 dose OP (8.67) Aerosol inhaler, 50 µg per dose CFC-free ........................ 7.50 120 dose OP (10.03) Aerosol inhaler, 125 µg per dose CFC-free .................... 13.60 120 dose OP (22.79) Aerosol inhaler, 250 µg per dose CFC-free .................... 27.20 120 dose OP (41.95) Flixotide Flixotide Flixotide Flixotide

Note: GlaxoSmithKline (GSK) has notified PHARMAC that although Flixotide is not fully subsidised in the Pharmaceutical Schedule, GSK is temporarily discounting stock to wholesalers so that there should be no surcharge to patients.

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy ‡ safety cap reimbursed Sole Subsidised Supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Subsidy and Manufacturer’s Price – effective 1 January 2003

23 CALCIUM CARBONATE (↑price)

Tab 420 mg and aminoacetic acid 180 mg with or without dimethicone 21 mg .................................... 30.00 (35.10) 1,000 Titralac

31 GLIPIZIDE (↓subsidy)

Tab 5 mg ......................................................................... 3.65 (6.10) 100 Minidiab Glipid

33 MUCILAGINOUS LAXATIVES - Only on a prescription (↓price)

Dry ................................................................................. 7.92 450 g OP (11.75) Isogel

35 BENZYDAMINE HYDROCHLORIDE - Retail pharmacy-specialist prescription (↑price)

Soln 0.15% ...................................................................... 9.00 (14.20) 500 ml Difflam

41 TRANEXAMIC ACID (↓subsidy)

Tab 500 mg ................................................................... 49.14 100 Cyklokapron

67 HYDROCORTISONE - Only on a prescription (↓subsidy)

Powder .......................................................................... 46.20 (47.87) (69.00) 25 g Apo-Hydrocortisone m-Hydrocortisone Pharmacia PSM

70 WOOL FAT WITH MINERAL OIL - Only on the prescription of a doctor (↑price)

Lotn hydrous 3% with mineral oil ..................................... 0.70 125 ml OP (5.01) Lotn hydrous 3% with mineral oil ..................................... 1.40 250 ml OP ............................................................................... (7.22) Lotn hydrous 3% with mineral oil ..................................... 5.60 1,000 ml (22.35) BK Lotion BK Lotion BK Lotion

81 PREGNANCY TEST - HCG URINE - Only on a WSO (↓subsidy)

25 ............................................................................... 29.50 (43.75) 25 tests MDS Quick Card MDS Quick Stick

96 COLISTIN SULPHOMETHATE - Hospital pharmacy [HP3]-specialist (↑subsidy)

a) Only if prescribed for a dialysis or cystic fibrosis patient; and b) The prescription is endorsed accordingly. Inj 150 mg ..................................................................... 49.54 Colymycin-M

L Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Changes to Subsidy and Manufacturer’s Price – effective 1 January 2003 (continued)

108 HEXAMINE HIPPURATE (↑price)

Tab 1 g .......................................................................... 18.40 (34.57) 100 Hiprex

110 IBUPROFEN (↑subsidy)

Tab 400 mg ................................................................... 15.20 Tab 600 mg ................................................................... 22.80 100 100 Brufen Brufen

Note: Full subsidy only available until 31 January 2003. 110 NAPROXEN (↓price)

Tab 250 mg ..................................................................... 6.00 Tab 500 mg ................................................................... 12.00 100 100 Naxen IMM Naxen IMM

111 INDOMETHACIN (↑subsidy)

Cap 25 mg ....................................................................... 5.50 Cap long-acting 75 mg .................................................. 12.50 Suppos 100 mg ............................................................. 12.00 100 100 30 Rheumacin Rheumacin SR Arthrexin

130 BUSPIRONE HYDROCHLORIDE - Special Authority (↓price)

Tab 10 mg ....................................................................... 5.95 100 BironIMM

139 INTERFERON BETA-1-ALPHA - Access by application (↓subsidy)

Inj 6 million iu per vial ............................................... 1,219.26 4 Avonex

139 INTERFERON BETA-1-BETA - Access by application (↓subsidy)

Inj 8 million iu per 1 ml ............................................. 1,347.26 15 Betaferon

Changes to Sole Subsidised Supply

Effective 1 March 2003

For the list of new Sole Subsidised Supply products effective 1 March 2003 refer to the bold entries in the cumulative Sole Subsidised Supply table pages 8–14.

Changes to PSO

Effective 1 February 2003

Beclomethasone dipropionate aerosol inhalers 50 µg, 100 µg and 250 µg per dose no longer subsidised on PSO.

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

‡ safety cap reimbursed Sole Subsidised Supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Delisted Items

Effective 1 March 2003

26 & 125 METOCLOPRAMIDE HYDROCHLORIDE

Inj 5 mg per ml, 2 ml - Available on a PSO ...................... 5.30 10 Pharmacia

44 BEZAFIBRATE

Tab 200 mg ..................................................................... 7.80 90 100 Slow Trasicor Bezalip

57 OXPRENOLOL

Tab long-acting 160 mg ................................................. 30.58 (42.00)

58 FELODIPINE

Tab long-acting 2.5 mg .................................................. 10.39 Tab long-acting 5 mg ..................................................... 14.08 Tab long-acting 10 mg ................................................... 21.04 90 90 90

Felo 2.5 ER Felo 5 ER Felo 10 ER

93 ERYTHROMYCIN - Available on a PSO

Cap 250 mg ................................................................... 14.95 (22.29) 100 Eryc 1440 Panadol

116 PARACETAMOL

Tab 500 mg - Available on a PSO ................................... 14.11 (15.84)

129 THIORIDAZINE HYDROCHLORIDE

Tab 10 mg ....................................................................... 6.38 90 Melleril

130 BUSPIRONE HYDROCHLORIDE - Special Authority

Tab 5 mg ......................................................................... 5.95 (35.74) Tab 10 mg ....................................................................... 5.95 (64.73) (64.72) 100 Biron 100 BironIMM BusparIMM

131 CHLORMETHIAZOLE EDISYLATE

Cap 192 mg - Month restriction ..................................... 10.52 (11.91) 50 Hemineurin

L Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Delisted Items – effective 1 March 2003 (continued)

147 BECLOMETHASONE DIPROPIONATE

Powder for inhalation, 100 µg per dose, 8 doses per disk .... 7.80 15 disks (10.20) Powder for inhalation, 400 µg per dose, 8 doses per disk .... 23.13 15 disks (29.40) Becodisk Junior

Becodisk Forte

153 AMINOPHYLLINE

‡ Oral liq 25 mg per ml - Retail pharmacy-specialist ........... 6.75 25 ml OP Biomed

Effective 1 February 2003

46 FLUVASTATIN

Cap 20 mg ....................................................................... 6.38 (23.10) Cap 40 mg ....................................................................... 7.51 (27.00) 30 Vastin 30 Vastin

69 & 169 AQUEOUS CREAM ......................................................... 2.65

(2.97)

500 g David Craig

69 & 169

EMULSIFYING OINTMENT BP .............................................. 4.09 (4.18) 500 g David Craig

74 & 168 PODOPHYLLIN

Paint 20% ..................................................................... CE a) Maximum 20 ml per prescription 20 ml

78 ETHINYLOESTRADIOL WITH LEVONORGESTREL - Available on a PSO

Tab ethinyloestradiol 50 µg with levonorgestrel 50 µg (11) and tab ethinyloestradiol 50 µg with levonorgestrel 125 µg (10) and 7 inert tab ......................................... 3.15 (4.60)

28 Biphasil 28

96 CO-TRIMOXAZOLE

Tab trimethoprim 80 mg and sulphamethoxazole 400 mg (Available on a PSO) ................................................. 20.80 500 Apo-Sulfatrim

118 AMOXAPINE

Tab 50 mg ..................................................................... 26.00 100 Asendin

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

‡ safety cap reimbursed Sole Subsidised Supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Delisted Items – effective 1 February 2003 (continued)

118 CLOMIPRAMINE HYDROCHLORIDE - Retail pharmacy-specialist

Tab 10 mg ..................................................................... 10.00 (17.50) 100 Anafranil

119 NORTRIPTYLINE HYDROCHLORIDE

Tab 10 mg ....................................................................... 4.50 (9.60) 100 Allegron

120 FLUOXETINE HYDROCHLORIDE

Tab dispersible 20 mg, scored ......................................... 4.90 (33.60) 30 Lovan Prozac 20

131 TEMAZEPAM - Month restriction

Cap 20 mg ....................................................................... 5.50 100 Somapam

131 ZOPICLONE - Month restriction

Tab 7.5 mg ...................................................................... 2.25 (2.80) 30 Zo-Tab

144 CETIRIZINE HYDROCHLORIDE

Tab 10 mg ....................................................................... 2.50 (26.00) 30 Zyrtec

149 FENOTEROL HYDROBROMIDE - Special Authority

Aerosol inhaler, 200 µg per dose ................................... 15.00 300 dose OP (18.00) Berotec

152 FENOTEROL HYDROBROMIDE WITH IPRATROPIUM BROMIDE - Special Authority

Aerosol inhaler, 100 µg with ipratropium bromide, 40 µg per dose ............................................................. 13.50 200 dose OP (18.00) Duovent Inhaler

154 THEOPHYLLINE

Tab long-acting 200 mg ................................................. 11.00 (12.00) 100 Theo-Dur

74 & 171 PODOPHYLLIN RESIN .................................................. 31.40

(34.50)

25 g PSM 227 g OP

179 RESOURCE THICKEN UP ............................................... 4.00

L Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Delisted Items – effective 1 January 2003

23 & 116 CODEINE PHOSPHATE

Tab 15 mg ....................................................................... 7.60 Tab 30 mg ..................................................................... 10.60 Tab 60 mg ..................................................................... 20.10 (22.00) 100 100 100 Douglas Douglas Douglas

24 SULPHASALAZINE

Suppos 500 mg ............................................................... 6.99 (7.50) 10 Salazopyrin

34 MUCILAGINOUS LAXATIVES - Only on a prescription

Dry ................................................................................. 2.64 150 g OP (4.75) Isogel

35 TRIAMCINOLONE ACETONIDE

0.1% in Dental Paste USP ................................................ 4.66 (8.08) 5 g OP Kenalog in Orabase

46 SIMVASTATIN

Tab 10 mg ..................................................................... 11.10 Tab 20 mg ..................................................................... 13.50 Tab 40 mg ..................................................................... 24.00 30 30 30 Zocor Zocor Zocor

53 LISINOPRIL

Tab 5 mg ......................................................................... 4.91 (12.28) Tab 10 mg ....................................................................... 7.14 (17.86) Tab 20 mg ..................................................................... 10.10 (25.27) 30 Zestril 30 Zestril 30 Zestril

54 LISINOPRIL WITH HYDROCHLOROTHIAZIDE

Tab 20 mg with hydrochlorothiazide 12.5 mg ................ 10.70 (38.04) 30 Prinzide Zestoretic

57 PINDOLOL WITH CLOPAMIDE

Tab 10 mg with clopamide 5 mg ...................................... 3.15 (7.10) 30 Viskaldix

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

‡ safety cap reimbursed Sole Subsidised Supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Delisted Items – effective 1 January 2003 (continued)

59 VERAPAMIL HYDROCHLORIDE

Tab long-acting 120 mg ................................................. 16.38 (20.65) Cap long-acting 120 mg ................................................ 16.38 (63.30) 250 Isoptin SR 250 Civicor Retard

66 BETAMETHASONE DIPROPIONATE

Crm 0.05% in propylene glycol base ............................... 4.33 30 g OP (12.20) Note: Diprosone OV listed 1 July 2002 to replace Diprolene cream. Diprolene

66 BETAMETHASONE VALERATE

Oint 0.1% ......................................................................... 1.20 30 g OP (5.38) Bivate

73 TAR WITH TRIETHANOLAMINE LAURYL SULPHATE AND FLUORESCEIN - Only on the prescription of a doctor

Soln 2.3% with triethanolamine lauryl sulphate and fluorescein sodium .................................................. 0.44 100 ml OP (2.42) Soln 2.3% with triethanolamine lauryl sulphate and fluorescein sodium .................................................. 0.88 200 ml OP (4.43)

Pinetarsol

Pinetarsol Pinetarsol Shower Pack

80 TIOCONAZOLE

Pessaries 100 mg with applicator .................................... 2.75 (9.20) 3 Gyno-Trosyd

83 PAMIDRONATE DISODIUM - Special Authority

Inj 3 mg per ml, 10 ml ................................................... 79.95 (157.50) 1 Aredia

84 & 113 METHYLPREDNISOLONE SODIUM SUCCINATE - Retail pharmacy-specialist

Inj 500 mg ..................................................................... 39.16 Inj 1 g ............................................................................ 70.95 1 1 Baxter Baxter

89 NAFARELIN ACETATE - Special Authority

Nasal soln 2 mg per ml ................................................ 277.00 10 ml OP Synarel

L Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Delisted Items – effective 1 January 2003 (continued)

90 DANAZOL - Retail pharmacy-specialist

Cap 100 mg ................................................................... 18.00 (21.11) Cap 200 mg ................................................................... 26.00 (34.85) 30 Danocrine 30 Danocrine

94 AMOXYCILLIN

Drops 125 mg per 1.25 ml .............................................. 3.17 20 ml OP Amoxil

97 GENTAMICIN SULPHATE - Hospital pharmacy [HP3]

a) Only if prescribed for a dialysis or cystic fibrosis patient or for prophylaxis of endocarditis and; b) The prescription is endorsed accordingly. Inj 40 mg per ml, 2 ml ..................................................... 5.70 10 (10.00) Baxter

107 ZALCITABINE (ddC) - Special Authority

Tab 750 µg .................................................................. 344.50 100 Hivid

130 CHLORDIAZEPOXIDE HYDROCHLORIDE - Month restriction

Cap 5 mg ......................................................................... 4.77 (5.35) Cap 10 mg ....................................................................... 4.95 (5.54) 100 Nova-Pam 100 Nova-Pam

133 CYTARABINE - Retail pharmacy-specialist

Inj 1 g .......................................................................... 118.00 Inj 2 g .......................................................................... 150.00 each each Pharmacia Pharmacia

134 METHOTREXATE - Hospital pharmacy [HP1]-specialist

Inj 500 mg, 20 ml vial [HP1] ......................................... 80.25 (82.66) each Pharmacia

147 BECLOMETHASONE DIPROPIONATE

Powder for inhalation, 200 µg per dose, 8 doses per disk ......................................................... 13.50 15 disks (18.90)

Becodisk 200

149 SALBUTAMOL - Available on a PSO

Powder for inhalation, 50 µg per dose, breath activated ....... 10.61 200 dose OP Salbutamol Turbuhaler

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

‡ safety cap reimbursed Sole Subsidised Supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Delisted Items – effective 1 January 2003 (continued)

154 PHOLCODINE

‡ Linctus BP ..................................................................... 11.00 2,000 ml (22.00) ‡ Linctus strong BP .......................................................... 13.00 2,000 ml (27.50) Douglas Douglas

156 & 158 BETAMETHASONE SODIUM PHOSPHATE

Ear/Eye drops 0.1% ......................................................... 4.50 5 ml OP Betnesol

156 & 158 BETAMETHASONE SODIUM PHOSPHATE WITH NEOMYCIN

Ear/Eye drops 0.1% with neomycin sulphate 0.5% .......... 4.50 5 ml OP Betnesol-N

159 DIPIVEFRIN HYDROCHLORIDE - Retail pharmacy-specialist

Eye drops 0.1% ............................................................... 5.90

10 ml OP

Dipoquin

L Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Items to be Delisted

Effective 1 September 2003

26 DICYCLOMINE HYDROCHLORIDE

Tab long-acting 40 mg ................................................... 13.00 100 Merbentyl Dospan

53 TRANDOLAPRIL

Cap 0.5 mg ...................................................................... 1.87 (11.43) 28 Gopten IMM

69 & 171 ZINC

Ointment BP .................................................................... 6.55 (8.90) 500 g PSM 84 Melodene

77 ETHINYLOESTRADIOL WITH GESTODENE - Available on a PSO

Tab 20 µg with gestodene 75 µg and 7 inert tab ............. 9.45 (Special Authority does not apply) (18.00) Note: Melodene tabs 1 x 28 listed 1 March 2003.

92 CEPHALOTHIN SODIUM - Hospital pharmacy [HP3]

Inj 1 g .............................................................................. 6.90 1 Keflin

116 PARACETAMOL

‡ Oral liq 120 mg per 5 ml .................................................. 8.10 1,000 ml a) available on a PSO b) not in combination (9.15) ‡ Oral liq 250 mg per 5 ml - Not in combination ................. 8.10 1,000 ml (9.15)

Douglas Douglas

144 CHLORPHENIRAMINE MALEATE

Cap long-acting 12 mg .................................................. 13.94 (21.81) 100 Histafen

147 FLUTICASONE

Powder for inhalation, 500 µg per dose, 4 doses per disk ............................................................ 28.92 15 disks (45.11)

Flixotide

154 THEOPHYLLINE

Tab long-acting 500 mg ................................................. 40.80 100 Nuelin-SR

169 GLYCEROL ................................................................... 26.66

2,000 ml David Craig

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

‡ safety cap reimbursed Sole Subsidised Supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Items to be Delisted – effective 1 August 2003

33 MUCILAGINOUS LAXATIVES - Only on a prescription

Dry ................................................................................. 5.72 325 g OP Konsyl D

44 GEMFIBROZIL

Cap 300 mg ..................................................................... 9.58 100 Gemizol

65 & 170 PHENOL

Liquified ......................................................................... 21.20 (29.70) 500 ml PSM

74 FORMALDEHYDE

Soln 37% ......................................................................... 8.50 500 ml 1 OP PSM Dumas Vault Vimule Prentif

76 CERVICAL CAP - Only on a WSO ................................... 6.71

116 PARACETAMOL

‡ Oral liq 120 mg per 5 ml .................................................. 8.10 1,000 ml a) Available on a PSO (9.15) b) Not in combination PSM Paracetamol Elixir Paediatric

133 CALCIUM FOLINATE - Hospital pharmacy [HP1] or [HP3]-specialist

Inj 50 mg [HP1] ............................................................. 29.95 (48.50) each Leucovorin 100 g PSM

170 METHYLCELLULOSE ....................................................... 16.11

(19.59)

170 METHADONE HYDROCHLORIDE

a) Only on a controlled drug form. b) Extemporaneously compounded methadone will only be reimbursed at the rate of the cheapest form available (methadone powder, not methadone tablets). Powder ....................................................................... 10.70 1g PSM

L Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Items to be Delisted – effective 1 July 2003

32 GLUCOSE OXIDASE

Blood diagnostic test with peroxidase ............................ 26.95 50 test OP Glucometer Esprit (36.11) Glucometer Elite

65 & 170 MENTHOL

Crystals ........................................................................... 8.05 (10.60) 25 g David Craig

65 & 170 PHENOL

Liquified ......................................................................... 21.20 (37.00) 500 ml David Craig

87 OESTRADIOL WITH NORETHISTERONE

TDDS 50 µg (10) and 1 mg norethisterone tab (12) ........ 5.40 (17.75) 1 OP Estrapak

97 FUSIDIC ACID - Hospital pharmacy [HP3]-specialist

Oral liq 250 mg per 5 ml ................................................ 50.15 90 ml Fucidin

97 NEOMYCIN SULPHATE - Hospital pharmacy [HP3]

Tab 500 mg ..................................................................... 9.95 25 Neosulf

122 PHENYTOIN SODIUM

L‡

Oral liq 100 mg per 5 ml ............................................. 15.83

500 ml

Dilantin Forte

123 ERGOTAMINE TARTRATE WITH DIPHENHYDRAMINE

Cap 1 mg with caffeine citrate 100 mg and diphenhydramine hydrochloride 25 mg .................................................... 8.81 50 Ergodryl

154 THEOPHYLLINE

Tab long-acting 300 mg ................................................. 14.07 100 Theo-Dur

156 COLISTIN SULPHATE WITH NEOMYCIN AND HYDROCORTISONE

Ear drops 3 mg with neomycin sulphate 3.3 mg and hydrocortisone acetate 10 mg per ml ............................. 9.00 5 ml OP Colymycin-S Otic

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

‡ safety cap reimbursed Sole Subsidised Supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Items to be Delisted – effective 1 June 2003

95 AMOXYCILLIN CLAVULANATE - Available on a PSO

Tab amoxycillin 500 mg with potassium clavulanate 125 mg 6.40 (7.48) Grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml ........................................ 2.75 (3.43) Grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml .......................................... 4.75 (5.89) 20 Synermox 100 ml Synermox 100 ml Synermox

122 CLONAZEPAM

L L

Tab 500 µg ...................................................................... 6.00 Tab 2 mg ....................................................................... 11.00

100 100

Rivotril Rivotril

129 FLUPHENAZINE DECANOATE - Retail pharmacy-specialist

Inj 12.5 mg per 0.5 ml, 0.5 ml - Available on a PSO ...... 17.60 (29.00) Inj 25 mg per ml, 1 ml - Available on a PSO .................. 27.90 (48.75) 5 Baxter 5 Baxter

Items to be Delisted – effective 1 May 2003

31 GLICLAZIDE

Tab 80 mg ..................................................................... 39.08 (78.80) 500 Diamicron

68 TRIAMCINOLONE ACETONIDE WITH GRAMICIDIN, NEOMYCIN AND NYSTATIN Only on a prescription

Crm 1 mg with nystatin 100,000 u, neomycin sulphate 2.5 mg and gramicidin 250 µg per g .............................. 3.49 15 g OP (6.09) Oint 1 mg with nystatin 100,000 u, neomycin sulphate 2.5 mg and gramicidin 250 µg per g .............................. 3.49 15 g OP (6.09)

Kenacomb

96 CIPROFLOXACIN - Retail pharmacy-specialist

L Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Items to be Delisted – effective 1 May 2003 (continued)

110 IBUPROFEN - Special Authority available

Tab 200 mg ..................................................................... 2.07 (2.90) 100 Panafen

110 NAPROXEN - Special Authority available

119 TRIMIPRAMINE MALEATE

Tab 25 mg ....................................................................... 3.19 (6.58) Cap 50 mg ..................................................................... 12.00 (23.00) 50 Surmontil 100 Surmontil

Items to be Delisted – effective 1 April 2003

31 GLIPIZIDE

Tab 5 mg ......................................................................... 3.65 (6.10) 100 Glipid 25 g Apo-Hydrocortisone Pharmacia PSM

67 HYDROCORTISONE - Only on a prescription

Powder .......................................................................... 46.20 (47.87) (69.00)

81 PREGNANCY TEST - HCG URINE - Only on a WSO

25 ............................................................................... 29.50 (43.75) 25 tests MDS Quick Stick

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

‡ safety cap reimbursed Sole Subsidised Supplier

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s Price) $ Per

Brand or Generic Mnfr fully subsidised

Section H changes effective 1 March 2003

Changes to Part 1 – General Rules for Hospital Pharmaceuticals

9. Pharmaceutical Cancer Treatments

9.1 DHBs are obliged to fund Pharmaceutical Cancer Treatments in accordance with the October 2001 direction from the Minister of Health. 9.2 The list of Pharmaceutical Cancer Treatments may be amended from time to time. Additions and/or amendments to Part V of Section H of the Pharmaceutical Schedule require the approval of the PHARMAC Board. 9.3 Pharmaceutical Cancer Treatments listed in Part V of Section H may be used in combination with each other, including where such combinations result in admixtures or dilutions that differ from those specified. 9.4 Subject to the provisions of clause 9.5, DHBs must not fund Pharmaceuticals for the treatment of cancer or Pharmaceutical Cancer Treatments for indications related to the treatment of cancer, if they are not listed in Part V of Section H of the Pharmaceutical Schedule, unless they have specific Community Exceptional Circumstances approval or permission under Hospital Exceptional Circumstances. 9.5 DHBs may fund Pharmaceuticals that are not listed in Part V of Section H of the Pharmaceutical Schedule, and/or Pharmaceutical Cancer Treatments for indications not listed in Part V (or subsidised via Sections A-G) of Section H of the Pharmaceutical Schedule, provided that: (a) such use is first assessed via established review mechanisms within DHB Hospitals involving experienced clinicians; (b) such use is reported to the Exceptional Circumstances Panel within 7 working days of initiating such treatment; and (c) the pharmaceutical or indications approved via this mechanism do not include those that have been assessed by the Pharmacology and Therapeutics Advisory Committee or its cancer treatments subcommittee and were not recommended for inclusion in Part V of Section H of the Pharmaceutical Schedule. 9.6 Applications to add pharmaceuticals, and add or amend indications for Pharmaceutical Cancer Treatments, to Part V of Section H of the Pharmaceutical Schedule may be made in writing by pharmaceutical suppliers and/or clinicians to PHARMAC. Applications should follow PHARMAC’s Guidelines for Submissions to PTAC for New Chemical Entity Pharmaceuticals and Recommended methods to derive clinical inputs for proposals to PHARMAC, copies of which are available from PHARMAC or PHARMAC’s website. 9.7 Applications made under clause 9.6 must be assessed by HPAC, PHARMAC, PTAC and/or relevant subcommittees of PTAC.

Changes to Part II – Pharmaceuticals under National Contracts

Contracted Pharmaceutical Description Brand Price ($) Per (ex man. excl. GST) DV Limit DV Limit applies from DV Pharmaceutical

GLYCERYL TRINITRATE

Aerosol spray 400 µg per dose 200 dose CFC-free

Glytrin

6.99

0% 5% Apr-03

Nitrolingual pumpspray

L Three

months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

“IMM” Interchangeable Multi-source Medicines

Index

Pharmaceuticals and brands

Accutrend ........................................................... 19 Adalat 10 ............................................................ 19 Adalat Oros ......................................................... 19 Advantage II ........................................................ 19 Allegron .............................................................. 27 Aminophylline ..................................................... 26 Amlodipine .......................................................... 19 Amoxapine .......................................................... 27 Amoxil ................................................................ 30 Amoxycillin ......................................................... 30 Amoxycillin clavulanate ........................ 16, 20, 35 Anafranil ............................................................. 27 Apo-Gliclazide ..................................................... 20 Apo-Hydrocortisone .................................... 23, 37 Apo-Pyridoxine ................................................... 21 Apo-Sulfatrim ...................................................... 27 Aqueous cream ................................................... 26 Aredia ................................................................. 29 Arthrexin ............................................................. 24 Ascensia Glucodisc ..................................... 16, 19 Asendin ............................................................... 27 Augmentin ................................................... 16, 20 Avonex ................................................................ 24

Cabergoline ......................................................... 20 Calcium carbonate .............................................. 23 Calcium folinate .................................................. 33 Ceftriaxone sodium ............................................. 21 Cephalothin sodium ............................................ 32 Cervical cap ........................................................ 33 Cetirizine hydrochloride ....................................... 27 Chlordiazepoxide hydrochloride .......................... 30 Chlormethiazole edisylate ................................... 26 Chlorpheniramine maleate ................................... 32 Cipflox ......................................................... 21, 22 Ciprofloxacin ................................................ 21, 36 Ciproxin ............................................... 21, 22, 36 Civicor Retard ..................................................... 29 Clomipramine hydrochloride ............................... 27 Clonazepam ......................................... 16, 20, 35 Co-trimoxazole .................................................... 27 Codeine phosphate ............................................. 28 Colistin sulphate with neomycin and hydrocortisone ...................................... 35 Colistin sulphomethate ........................................ 24 Colymycin-M ...................................................... 24 Colymycin-S Otic ................................................ 35 Cyklokapron ........................................................ 23 Cytarabine ........................................................... 30

Beclomethasone dipropionate .............. 25, 26, 30 Becodisk 200 ...................................................... 31 Becodisk Forte .................................................... 26 Becodisk Junior .................................................. 26 Benzydamine hydrochloride ................................ 23 Berotec ............................................................... 27 Betaferon ............................................................ 24 Betamethasone dipropionate ............................... 29 Betamethasone sodium phosphate ..................... 31 Betamethasone sodium phosphate with neomycin ............................................. 32 Betamethasone valerate ...................................... 29 Betnesol .............................................................. 31 Betnesol-N .......................................................... 32 Bezafibrate .......................................................... 25 Bezalip ................................................................ 25 Biphasil 28 .......................................................... 27 Biron ............................................................ 24, 26 Bivate .................................................................. 29 BK Lotion ............................................................ 23 BM-Test 1-44 ...................................................... 19 Brufen .......................................................... 22, 24 Buspar ................................................................ 26 Buspirone hydrochloride .............................. 24, 25

Daktarin .............................................................. 21 Danazol ............................................................... 30 Danocrine ........................................................... 30 ddC ..................................................................... 30 Depo-Provera ...................................................... 15 Dextropropoxyphene with paracetamol ............... 22 Diamicron ............................................ 19, 20, 35 Dicyclomine hydrochloride .................................. 32 Difflam ................................................................ 23 Dilantin Forte ...................................................... 34 Dipivefrin hydrochloride ...................................... 32 Dipoquin ............................................................. 32 Diprolene ............................................................ 29 Dostinex .............................................................. 20 Dumas Vault ....................................................... 33 Duovent Inhaler ................................................... 27

Emulsifying ointment BP ..................................... 26 Ergodryl .............................................................. 35 Ergotamine tartrate with diphenhydramine .......... 34 Eryc .................................................................... 25 Erythromycin ...................................................... 25 Erythropoietin beta .............................................. 18

Estrapak .............................................................. 34 Ethinyloestradiol with gestodene .................. 15, 32 Ethinyloestradiol with levonorgestrel ................... 26

Interferon beta-1-beta ......................................... 24 Isogel ........................................................... 23, 28 Isoptin SR ........................................................... 29

Felo 10 ER .......................................................... 25 Felo 2.5 ER ......................................................... 25 Felo 5 ER ............................................................ 25 Felodipine .................................................... 19, 25 Fenoterol hydrobromide ...................................... 27 Fenoterol hydrobromide with ipratropium bromide ............................. 27 Fergon ................................................................. 21 Ferrous gluconate ............................................... 21 Flixotide ............................................... 22, 23, 33 Fluocinolone acetonide ....................................... 21 Fluoxetine hydrochloride ..................................... 27 Fluphenazine decanoate ................ 15, 16, 20, 35 Fluticasone .................................................. 22, 32 Fluvastatin ........................................................... 26 Formaldehyde ..................................................... 33 Fucidin ................................................................ 34 Fusidic acid ......................................................... 34

Keflin .................................................................. 32 Kenacomb ............................................ 21, 35, 36 Kenalog in Orabase ............................................. 28 Konsyl D ............................................................. 33

Leucovorin .......................................................... 33 Lisinopril ............................................................. 28 Lisinopril with hydrochlorothiazide ...................... 29 Lovan .................................................................. 27

m-Hydrocortisone ............................................... 23 MDS Quick Card ................................................. 24 MDS Quick Stick .......................................... 24, 37 Medroxyprogesterone acetate ............................. 15 Melleril ................................................................ 25 Melodene ..................................................... 15, 32 Menthol ........................................................ 21, 34 Merbentyl Dospan ............................................... 32 Methadone hydrochloride .................................... 34 Methotrexate ....................................................... 30 Methylcellulose ................................................... 33 Methylprednisolone sodium succinate ................ 30 Metoclopramide hydrochloride ............................ 25 Miconazole nitrate ............................................... 21 Minidiab .............................................................. 23 Modecate ............................................. 15, 16, 20 Mucilaginous laxatives ......................... 23, 28, 33

Gemfibrozil ......................................................... 33 Gemizol ............................................................... 33 Gentamicin sulphate ........................................... 30 Gliclazide ............................................. 19, 20, 35 Glipid ........................................................... 23, 37 Glipizide ....................................................... 23, 37 Glivec .................................................................. 17 Glucocard ........................................................... 19 Glucometer Elite ........................................... 19, 34 Glucometer Esprit ........................................ 19, 34 Glucose oxidase ................................... 16, 19, 34 Glycerol ....................................................... 20, 33 Glyceryl trinitrate ................................................. 19 Gopten ................................................................ 32 Gyno-Trosyd ....................................................... 29

Nafarelin acetate .......................................... 16, 30 Naprosyn ..................................................... 22, 36 Naprosyn Enteric ......................................... 22, 36 Naproxen ............................................. 22, 24, 36 Naxen .......................................................... 22, 24 Neomycin sulphate ............................................. 34 Neosulf ............................................................... 34 Nifedipine ............................................................ 19 Nortriptyline hydrochloride .................................. 27 Norvasc .............................................................. 19 Nova-Pam ........................................................... 30 Nuelin-SR ........................................................... 33

Hemineurin ......................................................... 26 Hexamine hippurate ............................................ 24 Hiprex ................................................................. 24 Histafen .............................................................. 32 Hivid ................................................................... 30 Hydrocortisone ............................................ 23, 37 Hydrogen peroxide .............................................. 20 Hypam ................................................................ 15

Oestradiol with norethisterone ............................. 34 Ondansetron ....................................................... 22 Ondansetron hydrochloride ................................. 15 Oxprenolol ........................................................... 25

I-Profen ............................................................... 22 Ibuprofen ............................................. 22, 24, 36 Imatinib mesylate ................................................ 17 Indomethacin ...................................................... 24 Interferon beta-1-alpha ....................................... 24

Pamidronate disodium ......................... 15, 21, 29 Pamisol ............................................................... 15 Panadol ............................................................... 25

Panafen ........................................................ 22, 36 Paracetamol ......................................... 25, 32, 33 Paradex ............................................................... 22 Paxam .......................................................... 16, 20 Phenol ......................................................... 33, 34 Phenytoin sodium ............................................... 34 Pholcodine .......................................................... 31 Pindolol with clopamide ...................................... 29 Pinetarsol ............................................................ 29 Pinetarsol Shower Pack ...................................... 29 Plendil ER ........................................................... 19 Podophyllin ......................................................... 26 Podophyllin resin ................................................ 28 Precision Plus ..................................................... 19 Pregnancy test - HCG urine .......................... 24, 37 Prentif ................................................................. 33 Prinzide ............................................................... 29 Prozac 20 ........................................................... 27 PSM Paracetamol Elixir Paediatric ....................... 33 Pyridoxine hydrochloride ..................................... 20

Tar with triethanolamine lauryl sulphate and fluoroscein ............................................ 29 Temazepam ......................................................... 27 Theo-Dur ..................................................... 28, 35 Theophylline ........................................ 28, 33, 35 Thioridazine hydrochloride .................................. 25 Timolol maleate .................................................. 15 Timoptol ............................................................. 15 Tioconazole ........................................................ 29 Titralac ................................................................ 23 Trandolapril ......................................................... 32 Tranexamic acid .................................................. 23 Triamcinolone acetonide ..................................... 28 Triamcinolone acetonide with gramicidin, neomycin and nystatin .......................... 21, 35 Triazolam ............................................................ 15 Trimipramine maleate ................................... 22, 36 Tripress ............................................................... 22

Vastin .................................................................. 26 Verapamil hydrochloride ..................................... 29 Viaderm KC ......................................................... 21 Vimule ................................................................ 33 Viskaldix ............................................................. 29

Recormon ........................................................... 18 Resource Thicken Up .......................................... 28 Rheumacin .......................................................... 24 Rheumacin SR .................................................... 24 Rivotril ......................................................... 20, 35 Rocephin IM or IV ............................................... 21

Wool fat with mineral oil ...................................... 23

Salazopyrin ......................................................... 28 Salbutamol .......................................................... 31 Salbutamol Turbuhaler ........................................ 31 Simvastatin ......................................................... 28 Slow Trasicor ...................................................... 25 Somapam ........................................................... 27 Sulphasalazine .................................................... 28 Surmontil ..................................................... 22, 36 Synalar Gel ......................................................... 21 Synarel ........................................................ 16, 30 Synermox .................................................... 20, 35

Zalcitabine .......................................................... 30 Zestoretic ............................................................ 29 Zestril .................................................................. 28 Zinc ointment ...................................................... 32 Zo-Tab ................................................................. 27 Zocor .................................................................. 28 Zofran ................................................................. 22 Zofran Zydis ........................................................ 15 Zopiclone ............................................................ 27 Zyrtec ................................................................. 27

While care has been taken in compiling this Update, Pharmaceutical Management Agency takes no responsibility for any errors or omissions and shall not be liable to any person for any damages or loss arising out of reliance by that person for any purpose on any of the contents of this Update. Errors and omissions brought to the attention of Pharmaceutical Management Agency will be corrected if necessary by an erratum or otherwise in the next edition of the Update. Pharmaceutical Management Agency Level 1 Old Bank Chambers 98 Customhouse Quay PO Box 10 254 Wellington New Zealand Telephone 64 4 460 4990 Facsimile 64 4 460 4995 Freephone information line (9 am – 4 pm weekdays) 0800 66 00 50 http://www.pharmac.govt.nz

Metadata

Title

Schedule Update - effective 1 March 2003

Abstract

Page 1

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.